KENDALL JORDAN: Open Payments
NPI 1568230811 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 60 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,172 · 2025 $1,518
Food & beverage: $1,460Education: $59
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $498 |
| Lilly USA, LLC | 6 | $196 |
| GlaxoSmithKline, LLC. | 12 | $195 |
| ABBVIE INC. | 8 | $166 |
| GENZYME CORPORATION | 3 | $99 |
| Genentech USA, Inc. | 2 | $66 |
| Optinose US, Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $44 |
| BioCryst US Sales Co., LLC | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
Products named: DUPIXENT, EBGLYSS, NUCALA, QULIPTA, Xolair, Xhance, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
